MiRxes Raises $77M in Series C Round to Speed Progress of Early Cancer Detection Tests
The Singapore-based company's tests look for blood-borne microRNA and other molecular signatures released by cancer and immune cells.
Lucence, Waseda University Partner to Develop Laser-Based Liquid Biopsy Platform
The partners believe the platform, which captures high resolution images of CTCs and clusters, has potential applications in early cancer detection and disease monitoring.
MiRxes Receives CE Mark, Singapore Regulatory Approval for Multiplex SARS-CoV-2, Flu Test
The kit was jointly developed by Singapore's Agency for Science, Technology, and Research, Tan Tock Seng Hospital, and MiRxes.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
In Brief This Week: LabCorp, Intermountain Health, Progenity, and More
News items for the in vitro diagnostics industry for the week of Oct. 26, 2020.
Nov 25, 2019
A*STAR Spinoff, IMCB Establish Immuno-Oncology Lab
Jul 10, 2019
One BioMed Raises $5M in Series A Round
Dec 14, 2017
Nov 21, 2017
Dec 16, 2016